Weight Loss with Canaglifozin Linked to Improvement in Nonalcoholic Fatty Liver Disease
Clinicians frequently overlook nonalcoholic fatty liver disease in their patients who have Type 2 diabetes. Yet it is estimated that approximately 70% of obese鈥�
Stories and news
-
-
Collaborating for Better Outcomes in Patients with Fatty Liver Disease
Nonalcoholic fatty liver disease is a growing worldwide health problem and has been linked to common disorders such as Type 2 diabetes and cardiovascular鈥�
-
The Search Continues for a Noninvasive Test for Nonalcoholic Steatohepatitis that Works in the Real World
Nonalcoholic steatohepatitis, or NASH, is a serious progression of nonalcoholic fatty liver disease. Percutaneous liver biopsy is currently the gold standard鈥�
-
Head-on Approach to a Growing Crisis
Dear colleagues, At University of Florida, the Division of Endocrinology, Diabetes and Metabolism is conducting leading-edge research to learn more about the鈥�
-
Thinking 鈥淔ast鈥� May Improve Outcomes in Obese Adults with Type 2 Diabetes and Fatty Liver Disease
Despite decades of research and thousands of articles on the subject, clinicians are no closer to finding the ideal diet for patients with diabetes than when鈥�
